Objective—To test the hypothesis that application of a rope restraint device would result in behavioral, electroencephalographic, and humoral changes consistent with sleep and analgesia in neonatal foals.
Animals—8 healthy neonatal foals.
Procedures—Following acclimatization to experimental conditions, each foal underwent a series of assessments before and during or at the end of a period of restraint via application of a restraint device (soft linen rope). Assessments included measurements of heart and respiratory rates, rectal temperature, and circulating β-endorphin and steroid hormone concentrations and evaluations of mentation and body position (behavior), electroencephalographic patterns, and pain tolerance.
Results—All foals were lively with apparently normal behavior prior to restraint. During application of the restraint device, foals assumed lateral recumbency with relaxed, somnolent behavior. Heart and respiratory rates and rectal temperature uniformly decreased as a result of the procedure. Electroencephalographic recordings (completed for 3 foals only) revealed patterns consistent with slow wave sleep. Plasma ACTH, dehydroepiandrosterone sulfate, and androstenedione concentrations significantly increased during restraint, compared with prerestraint values. The foals' tolerance to noxious stimuli significantly increased during restraint; however, this was independent of the concentration of circulating β-endorphin.
Conclusions and Clinical Relevance—In neonatal foals, the evaluated form of restraint resulted in a decrease in heart and respiratory rates and rectal temperature. Squeeze-induced somnolence may resemble the effects of compression of the fetus in the birth canal and lead to inhibition of voluntary activity. Use of this technique to safely restrain neonatal foals during minor procedures warrants further evaluation.
Objective—To determine concentrations of 17α-hydroxyprogesterone (17OHP) in serum of healthy bitches during various stages of the reproductive cycle and in bitches with hyperadrenocorticism and to compare the dynamics of 17OHP with those of progesterone.
Design—Prospective evaluation study.
Animals—15 healthy sexually intact bitches and 28 spayed bitches with hyperadrenocorticism.
Procedures—11 healthy bitches were evaluated during estrus, nonpregnant diestrus, and anestrus (group 1); 4 other healthy bitches were evaluated during pregnancy and after ovariohysterectomy (group 2). Cycle stages were determined via physical examination, vaginal cytologic evaluation, and serum progesterone concentration. Bitches with hyperadrenocorticism were evaluated once at the time of diagnosis (group 3). Serum hormone concentrations were determined with immunoassays.
Results—In group 1, the serum 17OHP concentration was significantly higher in diestrus (median, 1.8 ng/mL) than in estrus (median, 1.1 ng/mL) and anestrus (median, 0.2 ng/mL) and higher in estrus than in anestrus. Changes in serum progesterone concentrations accounted for 22% (estrus) or 23% (diestrus) of the variation in serum 17OHP concentrations. In group 2, 17OHP and progesterone concentrations were significantly higher during pregnancy than after ovariohysterectomy. The serum 17OHP concentration in group 3 was significantly lower (median, 0.2 ng/mL) than in group 1 in estrus and diestrus and in group 2 during pregnancy (median, 0.7 ng/mL) but was not different from 17OHP concentrations in anestrus or after ovariohysterectomy (median, 0.2 ng/mL).
Conclusions and Clinical Relevance—Serum 17OHP concentrations in healthy bitches increased during estrus, diestrus, and pregnancy and at those times were higher than in spayed bitches with hyperadrenocorticism.